Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT).
Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT).
复制标题
DOI:
10.1016/j.oraloncology.2021.105328
复制
发表时间:
2021-08
期刊:
影响因子:
4.8
通讯作者:
Diefenbach, Michael A.
中科院分区:
文献类型:
--
作者:
Teckie, Sewit;Wotman, Michael;Marziliano, Allison;Orner, David;Yi, Jungen;Mulvany, Colm;Ghaly, Maged;Parashar, Bhupesh;Diefenbach, Michael A.
Alcohol use among survivors of head and neck cancer (HNC) negatively impacts patient outcomes and is an important risk factor for recurrent and second primary tumors. Despite recommendations from several cancer societies, alcohol consumption remains a common problem in this population. A cross-sectional study was performed with the Alcohol Use Disorders Identification Test (AUDIT) Self- Report questionnaire. Patients with HNC completed surveys at pre-treatment and follow-up appointments every 3–6 months for at least 2-years after treatment. 796 surveys were available for analysis. Most participants were male (75.7%) and had either oropharyngeal (34.5%) or laryngeal (16.7%) cancer. The percentage of alcohol drinkers decreased from 56.1% at pre- treatment to 40.4% at 0–3 months post-treatment, but then increased and surpassed baseline levels by 24 + months post-treatment (64.4%, p = 0.0079). Concurrently, moderate drinkers (AUDIT = 1 – 3) decreased from 34.2% at pre-treatment to 25.2% at 0–3 months post-treatment, but then increased and surpassed baseline levels at 24 + months post-treatment (39.7%, p = 0.0129). Trends among heavy (AUDIT > 3), and heaviest (AUDIT > 6) drinkers were similar, but not statistically significant. At 24 + months post-therapy, we observed a statistically significant increase in female users (39.1% to 63.2%, p = 0.0213) and moderate drinkers < 55 years old (43.4% to 61.9%, p = 0.0184). Alcohol consumption in survivors of HNC transiently decreases in the immediate months after treatment, but then increases and remains largely stable by 24 months. This pattern is particularly concerning and highlights the need for timely interventions.
登录
查看更多内容
DOI:
10.1016/s0140-6736(18)32203-7
发表时间:
2018-11-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
GBD 2017 Causes of Death Collaborators
通讯作者:
GBD 2017 Causes of Death Collaborators
DOI:
10.6004/jnccn.2019.7341
发表时间:
2020-01-01
影响因子:
13.4
作者:
Sanford, Nina N.;Sher, David J.;Mahal, Brandon A.
通讯作者:
Mahal, Brandon A.
影响因子:
45.3
作者:
Gritz, ER;Carmack, CL;Abemayor, E
通讯作者:
Abemayor, E
影响因子:
13.6
作者:
Leoncini E;Vukovic V;Cadoni G;Giraldi L;Pastorino R;Arzani D;Petrelli L;Wünsch-Filho V;Toporcov TN;Moyses RA;Matsuo K;Bosetti C;La Vecchia C;Serraino D;Simonato L;Merletti F;Boffetta P;Hashibe M;Lee YA;Boccia S
通讯作者:
Boccia S
影响因子:
3.4
作者:
Simcock, R.;Simo, R.
通讯作者:
Simo, R.